Giovanni Villa

Jan 11, 2025 | sti.bmj.com | Drieda Zace |Marina Daskalopoulou |Rachel Herbert |Giovanni Villa

Viral suppression (VS) following initiation of long-acting cabotegravir/rilpivirine (LA-CAB/RPV) among people with HIV, adherence challenges and baseline viraemiaThe Ward 86 publicly funded San Francisco HIV clinic serves people experiencing socioeconomic, psychological and adherence challenges. This study examined the persistence of LA-CAB/RPV and durability of VS (HIV RNA <50 c/mL) at 48 weeks among 59 participants (53% unstable housing, 63% substance use and 49% CD4 <200 cells/mm3).

Nov 18, 2024 | sti.bmj.com | Nadja A. Vielot |Weiming Tang |Giovanni Villa

Published in STI: men who have sex with men frequently receive antibiotics despite negative STI testsThe Sydney Sexual Health Centre guidelines indicate immediate presumptive antibiotic treatment for men who have sex with men (MSM) with anogenital symptoms, in addition to laboratory-based three-site molecular testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoea (GC).

Aug 19, 2024 | sti.bmj.com | Stefano Rusconi |Giovanni Villa |Tropical Diseases |Acquired Immunodeficiency

Cefixime + doxycycline is less effective against pharyngeal gonorrhoea than ceftriaxone + azithromycinIn a randomised controlled trial, 161 patients diagnosed with uncomplicated urogenital, rectal or pharyngeal gonorrhoea were treated with either single-dose cefixime (800 mg) plus doxycycline (100 mg two times per day for 7 days) or single-dose ceftriaxone (1 g) plus single-dose azithromycin (2 g). At week 1, both treatment arms achieved 100% microbiological clearance.

Jan 17, 2024 | sti.bmj.com | Giovanni Villa |Drieda Zace |Sonia F Raffe

Pay-it-forward incentives as a strategy to increase hepatitis B and C testing in the communityPay-it-forward incentives involve offering a free test and then giving a chance to donate money to support testing of another anonymous person.

Jul 25, 2023 | sti.bmj.com | Giovanni Villa |Marina Daskalopoulou

Voluntary medical male circumcision continues to be a cost-effective HIV prevention strategy in sub-Saharan AfricaWith increasing availability of antiretroviral treatment and HIV pre-exposure prophylaxis (PrEP), it was unclear whether male circumcision would continue to provide a cost-effective HIV prevention strategy in sub-Saharan Africa.